NewsRoom Articles - Page 857 of 1466

ThursdayMay 23, 2019 2:30 pm

Arbutus Biopharma Corp. (ABUS) Starts Presentation at B. Riley Conference

Arbutus Biopharma (NASDAQ: ABUS) is a biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). Arbutus is developing a portfolio of drug candidates with complementary mechanisms of action that it believes will result in the company’s first novel combination regimen that will transform the HBV treatment landscape and cure hepatitis B virus disease. For more information, visit the company's website at www.arbutusbio.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a…

ThursdayMay 23, 2019 2:30 pm

ArQule Inc. (ARQL) Starts Presentation at B. Riley Conference

ArQule (NASDAQ: ARQL) is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and certain rare diseases. ArQule’s mission is to discover, develop and commercialize novel small molecule drugs that will dramatically extend and improve the lives of patients in areas of high unmet need. With four internally discovered drugs in multiple biomarker guided clinical trials and an enriched proprietary kinase library from which to select additional drug candidates, ArQule is delivering on the potential of precision medicine by providing its patients with novel therapies for multiple hard to treat indications. For more information,…

ThursdayMay 23, 2019 2:30 pm

Scorpio Tankers Inc. (STNG) Starts Presentation at B. Riley Conference

Scorpio Tankers (NYSE: STNG) is an international provider in the transportation of refined petroleum products. Scorpio Tankers currently owns or finance leases 109 product tankers (38 LR2 tankers, 12 LR1 tankers, 45 MR tankers and 14 Handymax tankers) and time or bareboat charters-in 10 product tankers (three MR tankers and seven Handymax tankers). For more information, visit the company's website at www.scorpiotankers.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article…

ThursdayMay 23, 2019 2:30 pm

Plug Power Inc. (PLUG) Starts Presentation at B. Riley Conference

Plug Power (NASDAQ: PLUG) is the innovator that has taken hydrogen and fuel cell technology from concept to commercialization. Plug Power has revolutionized the material handling industry with its full-service GenKey solution, which is designed to increase productivity, lower operating costs, and reduce carbon footprints in a reliable, cost-effective way. Plug Power replaces lead acid batteries to power electric industrial vehicles, such as the lift trucks customers use in their distribution centers. Extending its reach into the on-road electric vehicle market, Plug Power’s ProGen platform of modular fuel cell engines empowers OEMs and system integrators to rapidly adopt hydrogen fuel…

ThursdayMay 23, 2019 2:30 pm

BBX Capital Corp. (BBX) Starts Presentation at B. Riley Conference

BBX Capital (NYSE: BBX) is a Florida-based diversified holding company whose principal investments include its 90 percent ownership interest in Bluegreen Vacations Corporation (NYSE: BXG), as well as investments in BBX Capital Real Estate, Renin Holdings and IT’SUGAR. For more information, visit the company's website at www.BBXCapital.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum…

ThursdayMay 23, 2019 2:30 pm

Dolphin Entertainment Inc. (DLPN) Starts Presentation at B. Riley Conference

Dolphin Entertainment (NASDAQ: DLPN) is an independent entertainment marketing and premium content development company. Through its subsidiaries, 42West and The Door, the company provides expert strategic marketing and publicity services to many of the top brands, both individual and corporate, in the entertainment and hospitality industries. The Door and 42West are both recognized global leaders in PR services for their respective industries. Dolphin's recent acquisition of Viewpoint Creative adds full-service creative branding and production capabilities to its marketing group. Dolphin's legacy content production business, founded by Emmy-nominated CEO Bill O'Dowd, has produced multiple feature films and award-winning digital series. For…

ThursdayMay 23, 2019 2:30 pm

GP Strategies Corp. (GPX) Starts Presentation at B. Riley Conference

GP Strategies (NYSE: GPX) is a global performance improvement solutions provider of training, digital learning solutions, management consulting, and engineering services. GP Strategies' solutions improve the effectiveness of organizations by delivering innovative and superior training, consulting and business improvement services customized to meet the specific needs of its clients. Clients include Fortune 500 companies, manufacturing, process and energy industries, and other commercial and government customers. For more information, visit the company's website at www.gpstrategies.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target…

ThursdayMay 23, 2019 2:30 pm

Marrone Bio Innovations Inc. (MBII) Starts Presentation at B. Riley Conference

Marrone Bio Innovations (NASADAQ: MBII) discovers, develops and sells innovative biological products for crop protection, plant health and waterway systems treatment that support a better tomorrow for farmers, turf managers and consumers around the globe. MBI, with over 400 issued and pending patents, has screened over 18,000 microorganisms and 350 plant extracts, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies to rapidly develop seven effective and environmentally responsible pest management active ingredients and nine products to help customers operate more sustainably while uniquely improving plant health and increasing crop yields. For more information, visit…

ThursdayMay 23, 2019 2:00 pm

Churchill Capital Corp. (CCC) Starts Presentation at B. Riley Conference

Churchill Capital is a newly incorporated special purpose acquisition company formed as a Delaware corporation for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the company may pursue an initial business combination in any sector, it intends to focus its efforts on businesses in the broader technology services and software industry and, more specifically, the predictive analytics and data market. Churchill Capital is sponsored by Churchill Sponsor LLC, which is primarily owned by entities controlled by its co-founders, Michael Klein and Jerre Stead. For more…

ThursdayMay 23, 2019 2:00 pm

Viking Therapeutics Inc. (VKTX) Starts Presentation at B. Riley Conference

Viking Therapeutics (NASDAQ: VKTX) is a clinical-stage biopharmaceutical company focused on the development of novel, orally available, first-in-class or best-in-class therapies for the treatment of metabolic and endocrine disorders. Viking's research and development activities leverage its expertise in metabolism to develop innovative therapeutics designed to improve patients' lives. The company's clinical programs include VK2809, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders, including non-alcoholic steatohepatitis (NASH). In a phase 2 trial for the treatment of non-alcoholic fatty liver disease (NAFLD) and elevated LDL-C, patients who received VK2809 demonstrated…